Instil Bio, Inc. — Director's Dealing 2021

Mar 19, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-18

Reporting Person: Curative Ventures V LLC (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (30000000)		Direct
Series B Preferred Stock	$		Common Stock (6098799)		Direct
Series C Preferred Stock	$		Common Stock (1431274)		Direct

Footnotes

F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock is convertible at any time at the option of the
holder, without payment of additional consideration, into Common Stock, on a one for one basis, has no expiration date and is expected to
automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.